ClinicalTrials.Veeva

Menu

Bilateral Bispectral Index, Asymmetries and Post-operative Delirium (DELBIS)

S

Scientific Institute for Research Hospitalization and Healthcare (IRCCS)

Status

Enrolling

Conditions

Postoperative Delirium
Postoperative Cognitive Dysfunction

Treatments

Device: Bilateral Bispetral Index Monitor will be applied on forehead of our patients, before surgery begins

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

The primary objective of the study is to describe the value of interhemispheric asymmetry (ASYM), during the different intra- and peri-operative phases, in those patients who develop or do not develop post-operative delirium (POD) during the first 30 post-operative days and postoperative cognitive disfunction (POCD) in the first 90 post-operative days, in a population undergoing head&neck and plastic surgery with a priori increased probability of POD.

Full description

Values of the study variables will be extract in these specific moments (considering a delay of thirty seconds between the in vivo phenomenon and the instrument): (t1) BIS probe application (t2) 60" before GA administration (t3) 60" after myoresolution (t4) intubation (t5) surgical incision (t6) end of ipnosis (t7) 10 minutes after extubation. Daily follow-up for the first five post-operative days is performed in order to verify the onset of POD and a telephone follow-up at thirty and ninety post-operative days in order to verify the onset of POD / POCD.

CAM scale will be used for the diagnosis of POD; while for the diagnosis of POCD, 6-CIT test will be used, the EQ50 test in the case of tracheostomized patients.

Enrollment

84 estimated patients

Sex

All

Ages

18 to 90 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

-Patients, undergoing head&neck surgery, who have at least 3 of the following criteria (to establish "a priori" increased risk of POD):

  • Age> 70;
  • Male sex; or ASA III;
  • Smoker;
  • High blood pressure;

Exclusion criteria

  • ASA IV, V or ASA IE, IIE, IIIE (patients with anesthetic risk ASA>III and those undergoing urgent-emergency surgery will be excluded from the study);

  • Past positive medical history for:

    • Stroke;
    • Dementia;
    • Cerebral aneurysm;
    • Intracranial mass;
    • Head trauma;
    • Epilepsy;
    • Diabetes mellitus;
    • Previous neurosurgical intervention;
    • Psychiatric illnesses requiring chronic treatment;
  • Patients undergoing surgery in the previous two weeks;

  • Patients whose hospitalization duration is estimated to be less than five days;

  • Lack of understanding of the Italian language or English;

  • Age <18 years.

Trial design

84 participants in 1 patient group

Patiets, undergoing head and neck surgery or plastic surgery, with high risk of POD
Description:
Each recruited patient, once on the operating bed, will be monitored with two BIS sensor, applied on the forehead in a non-invasive way, each for hemisphere. BIS Vista® monitor will be connected to our off-line laptop and software VitalDB will record: right\&left BIS, BSR, Total Power, SEF, EMG, SQI and two BIS curves. Values of the study variables will be extract in these specific moments:(t1) BIS probe application (t2) 60" before GA administration (t3) 60" after myoresolution (t4) intubation (t5) surgical incision (t6) end of ipnosis (t7) 10 minutes after extubation. A daily follow-up for the first 5 post-operative days will verify the onset of POD and a telephone follow-up will be performed at 30 and 90 post-operative days to verify the onset of POD and POCD (CAM scale, 6-CIT scale and EQ50 for tracheostomized patients).
Treatment:
Device: Bilateral Bispetral Index Monitor will be applied on forehead of our patients, before surgery begins

Trial contacts and locations

1

Loading...

Central trial contact

Maria Paola Lauretta, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems